136 related articles for article (PubMed ID: 7463112)
1. A method for monitoring antifibrinolytic therapy in patients with ruptured intracranial aneurysms.
Burchiel KJ; Schmer G
J Neurosurg; 1981 Jan; 54(1):12-5. PubMed ID: 7463112
[TBL] [Abstract][Full Text] [Related]
2. Quantitative determination of plasma fibrinolytic activity in patients with ruptured intracranial aneurysms who are receiving epsilon-aminocaproic acid: relationship of possible complications of therapy to the degree of fibrinolytic inhibition.
Burchiel KJ; Hoffman JM; Bakay RA
Neurosurgery; 1984 Jan; 14(1):57-63. PubMed ID: 6537999
[TBL] [Abstract][Full Text] [Related]
3. Epsilon-aminocaproic acid and recurrent subarachnoid hemorrhage: a clinical trial.
Shucart WA; Hussain SK; Cooper PR
J Neurosurg; 1980 Jul; 53(1):28-31. PubMed ID: 7411206
[TBL] [Abstract][Full Text] [Related]
4. Antifibrinolytic therapy in subarachnoid hemorrhage caused by ruptured intracranial aneurysm.
Ramirez-Lassepas M
Neurology; 1981 Mar; 31(3):316-22. PubMed ID: 7010208
[TBL] [Abstract][Full Text] [Related]
5. Clinical and laboratory investigation of the effects of epsilon-aminocaproic acid on hemostasis.
Green D; Ts'ao CH; Cerullo L; Cohen I; Ruo TI; Atkinson AJ
J Lab Clin Med; 1985 Mar; 105(3):321-7. PubMed ID: 2982982
[TBL] [Abstract][Full Text] [Related]
6. [Antifibrinolytic treatment after subarachnoid hemorrhage].
Marchel A
Neurol Neurochir Pol; 1992; 26(4):502-10. PubMed ID: 1484577
[TBL] [Abstract][Full Text] [Related]
7. Fibrinolytic activity in blood and cerebrospinal fluid in subarachnoid hemorrhage from ruptured intracranial saccular aneurysm before and during EACA treatment.
Filizzolo F; D'angelo V; Collice M; Ferrara M; Donati MB; Porta M
Eur Neurol; 1978; 17(1):43-7. PubMed ID: 624294
[TBL] [Abstract][Full Text] [Related]
8. Use of epsilon aminocaproic acid (EACA) in the preoperative management of ruptured intracranial aneurysms.
Sengupta RP; So SC; Villarejo-Ortega FJ
J Neurosurg; 1976 Apr; 44(4):479-84. PubMed ID: 1255236
[TBL] [Abstract][Full Text] [Related]
9. Cerebral complication of antifibrinolytic therapy in the treatment of ruptured intracranial aneurysm. Animal experiment and a review of literature.
Yamaura A; Nakamura T; Makino H; Hagihara Y
Eur Neurol; 1980; 19(2):77-84. PubMed ID: 6893025
[TBL] [Abstract][Full Text] [Related]
10. Antifibrinolytic therapy in aneurysmal subarachnoid hemorrhage increases the risk for deep venous thrombosis: A case-control study.
Foreman PM; Chua M; Harrigan MR; Fisher WS; Tubbs RS; Shoja MM; Griessenauer CJ
Clin Neurol Neurosurg; 2015 Dec; 139():66-9. PubMed ID: 26378393
[TBL] [Abstract][Full Text] [Related]
11. Reducing the risk of rebleeding before early aneurysm surgery: a possible role for antifibrinolytic therapy.
Leipzig TJ; Redelman K; Horner TG
J Neurosurg; 1997 Feb; 86(2):220-5. PubMed ID: 9010423
[TBL] [Abstract][Full Text] [Related]
12. Antifibrinolytics in aneurysmal subarachnoid haemorrhage. A retrospective comparison of two different forms of antifibrinolytic therapy.
Spallone A
Acta Neurochir (Wien); 1982; 63(1-4):245-50. PubMed ID: 6179402
[TBL] [Abstract][Full Text] [Related]
13. Preoperative treatment of ruptured intracranial aneurysms with tranexamic acid and monitoring of fibrinolytic activity.
Alvarez Garijo JA; Vilches JJ; Aznar JA
J Neurosurg; 1980 Apr; 52(4):453-5. PubMed ID: 7373370
[TBL] [Abstract][Full Text] [Related]
14. Recurrent subarachnoid hemorrhage associated with aminocaproic acid therapy and acute renal artery thrombosis. Case report.
Tubbs RR; Benjamin SP; Dohn DE
J Neurosurg; 1979 Jul; 51(1):94-7. PubMed ID: 448423
[TBL] [Abstract][Full Text] [Related]
15. Anti-fibrinolytic treatment in the pre-operative management of subarachnoid haemorrhage caused by ruptured intracranial aneurysm.
Ameen AA; Illingworth R
J Neurol Neurosurg Psychiatry; 1981 Mar; 44(3):220-6. PubMed ID: 7229645
[TBL] [Abstract][Full Text] [Related]
16. Impact of a protocol for acute antifibrinolytic therapy on aneurysm rebleeding after subarachnoid hemorrhage.
Starke RM; Kim GH; Fernandez A; Komotar RJ; Hickman ZL; Otten ML; Ducruet AF; Kellner CP; Hahn DK; Chwajol M; Mayer SA; Connolly ES
Stroke; 2008 Sep; 39(9):2617-21. PubMed ID: 18658042
[TBL] [Abstract][Full Text] [Related]
17. [Effectiveness of antifibrinolytic, edema-preventing and hypotensive agents in the prevention of recurrent bleeding from intracranial aneurysms].
Bromowicz J; Bryniarska D; Koniar-Danilewicz H; Danilewicz B
Neurol Neurochir Pol; 1979; 13(6):647-51. PubMed ID: 514441
[TBL] [Abstract][Full Text] [Related]
18. Intracranial aneurysms and subarachnoid hemorrhage. A cooperative study. Antifibrinolytic therapy in recent onset subarachnoid hemorrhage.
Nibbelink DW; Torner JC; Henderson WG
Stroke; 1975; 6(6):622-9. PubMed ID: 1198627
[TBL] [Abstract][Full Text] [Related]
19. Streptokinase clot lysis time in patients with ruptured intracranial aneurysms.
Geronemus R; Herz DA; Shulman K
J Neurosurg; 1974 Apr; 40(4):499-503. PubMed ID: 4814382
[No Abstract] [Full Text] [Related]
20. Myoglobinuria following epsilon-aminocaproic acid (EACA) therapy. Case report.
Brodkin HM
J Neurosurg; 1980 Nov; 53(5):690-2. PubMed ID: 7431078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
